Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Trcka, J; Kampgen, E; Becker, JC; Schwaaf, A; Brocker, EB.
Immunochemotherapy of malignant melanoma. Epifocal administration of dinitrochlorobenzene (DNCB) combined with systemic chemotherapy with dacarbazine (DTIC)
Hautarzt. 1998; 49(1):17-22 Doi: 10.1007/s001050050695
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Becker Jürgen Christian
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
We describe an immunochemotherapy for metastatic melanoma that combines epifocal applications of the contact sensitizer DNCB over cutaneous metastases with systemic DTIC treatment. 4 complete remissions and 3 partial remissions were achieved in 15 patients. 6 of these remissions were seen in the 7 previously untreated patients. The advantages of this therapy which is in particular interesting for dermatologists are tolerable side effects and low costs. This publication is designed to stimulate larger randomized trials in order to answer open questions.
Find related publications in this database (using NLM MeSH Indexing)
Administration, Topical -
Adult -
Aged -
Aged, 80 and over -
Antineoplastic Agents - administration and dosage
Combined Modality Therapy -
Dacarbazine - administration and dosage
Dinitrochlorobenzene - administration and dosage
Female -
Follow-Up Studies -
Humans -
Immunotherapy -
Infusions, Intravenous -
Irritants - administration and dosage
Male -
Melanoma - drug therapy Melanoma - immunology Melanoma - pathology
Middle Aged -
Skin - drug effects Skin - pathology
Skin Neoplasms - drug therapy Skin Neoplasms - immunology Skin Neoplasms - pathology
Treatment Outcome -

Find related publications in this database (Keywords)
melanoma
cutaneous metastases
immunochemotherapy
dinitrochlorobenzene (DNCB)
dacarbazin (DTIC)
© Med Uni GrazImprint